Cargando…
Vitamins and hormones. advances in research and applications / Volume 58 :
This volume may be divided into three groups of contributors. The first five chapters deal with polypeptides: GnRG receptor and apoptotic signaling; structure and function of the growth hormone-releasing hormone receptor; regulators of growth hormone signaling; and the EGF domain--requirements for b...
| Clasificación: | Libro Electrónico |
|---|---|
| Otros Autores: | |
| Formato: | Electrónico eBook |
| Idioma: | Inglés |
| Publicado: |
San Diego, Calif. ; London :
Academic Press,
�2000.
|
| Colección: | Vitamins and hormones ;
v. 58. |
| Temas: | |
| Acceso en línea: | Texto completo Texto completo |
Tabla de Contenidos:
- Front Cover; Vitamins and Hormones; Copyright Page; Contents; Preface; Chapter 1. Protein Folding and Deficiencies Caused by Dominant-Negative Mutants of Hormones; I. Introduction; II. Functions of the Endoplasmic Reticulum Related to Protein Folding; III. Aspects of the Neuroendocrine Secretory Pathway; IV. Isolated Dominant-Negative Hormone Deficiency: Problems in the Secretory Pathway; V. Conclusions; References; Chapter 2. Structural Aspects of the G-Protein Receptor, Rhodopsin; I. Introduction; II. Seven Transmembrane Helical Hydrophobic Core of Rhodopsin.
- III. Structure of the Retinal and Its Binding Site in RhodopsinIV. Structure of Extramembranous Domains of Rhodopsin; V. Cytoplasmic Face of Rhodopsin; VI. Intradiskal Face of Rhodopsin; VII. Future Directions; References; Chapter 3. Molecular Modeling of Mammalian Cytochromes P450: Application to Study Enzyme Function; I. Introduction; II. Molecular Modeling Methods; III. Homology Models in Studies of P450 Function; IV. Perspectives and Conclusions; References; Chapter 4. Prostaglandin D Synthase: Structure and Function; I. Introduction.
- II. Pharmacologic Actions of Prostaglandin D2 and Its MetabolitesIII. Lipocalin-Type Prostaglandin D Synthase (�-Trace); IV. Hematopoietic Prostaglandin D Synthase; V. Future Studies; References; Chapter 5. Steroid Dehydrogenase Structures, Mechanism of Action, and Disease; I. Introduction; II. 3a,20� -Hydroxysteroid Dehydrogenase; III. Aldosterone, Cortisol, Licorice, and Hypertension; IV. 17� -Hydroxysteroid Dehydrogenase, Inhibitors, and Cancer; V. Protein Sequence and Three-Dimensional Conformation; VI. Conclusions; References; Chapter 6. Structure-Based Inhibitor Design; I. Introduction.
- II. Target Selection, Cloning, and Determination of 3-D StructuresIII. Crystallographic Water Molecules; IV. Computational Approaches to Lead Compound Discovery; V. Estimating the Theoretical Limits for Reversible Inhibitor Binding; VI. Connectivity, Flexibility, and Conformational Entropy; VII. Using Enzyme Structures in Dealing with Resistance Mutations; VIII. Conclusions; References; Chapter 7. Protein Folding Using Contact Maps; I. Introduction; II. Structure Representation; III. The Reconstruction Procedure; IV. Dynamics in Contact Map Space; V. Approximation for Free Energy; VI. Results.
- VII. ConclusionsReferences; Chapter 8. HIV Protease: Enzyme Function and Drug Resistance; I. Introduction; II. HIV PR Is a Member of the Aspartic Proteinase Family; III. HIV PR Structure; IV. Mechanism of the Substrate Cleavage and Protonation State of the Catalytic Aspartates; V. Substrate Specificity; VI. Assay Methods; VII. pH Optima; VIII. Dimer Stability; IX. Thermodynamic Characteristics of Inhibitor Binding; X. Inhibitors of HIV PR; XI. Introduction to Resistance to HIV PR Inhibitors; XII. Active Site Mutations; XIII. Nonactive Site Mutations; XIV. Cleavage Site Mutants.